SRRK Scholar Rock Quick Ratio

The current level of quick liquidity provided by GURU.Markets analytics is 6.72. Scholar Rock management focuses on developing cutting-edge treatments for muscle pathologies. The company is developing drugs for SMA and oncology by regulating protein signals. To mitigate risks during neurological drug trials, the business engages global contract research organizations.

SRRK: Scholar Rock Corp Intermediate Coverage Ratio 07/04/2022 - 10/29/2026

Analytical breakdowns for Scholar Rock

- market value and analyst target forecast:

Price Chart Scholar Rock Corp|SRRK - Consensus Target

- market capitalization data:

Market Capitalization Scholar Rock Corp|SRRK - Enterprise Value

- balance sheet net asset value indicators:

Accounting Value per Share Scholar Rock|SRRK - Accounting Value of Company|Market Value to Book Value Ratio scholarrock.com|SRRK - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Scholar Rock|SRRK - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Scholar Rock Holding Corporation|SRRK - Company Aggregate Debts|Debt to Book Capitalization Ratio Scholar Rock Corp|SRRK - Company Long-Term Loans and Borrowings|Company Short-Term Debt Scholar Rock|Quick Liquidity scholarrock.com

- earnings and valuation multiples information:

SRRK - Company Net Income

Initial company analysis:Scholar Rock

Flagship merchandise of Scholar Rock, Inc.

For Scholar Rock (SRRK), access to immediate resources is critical amid geopolitical instability and risks of bio-raw material supply chain disruptions. Analyzing the quick liquidity structure, an investor sees the company's ability to settle short-term obligations solely through cash and accounts receivable, excluding illiquid inventories, which confirms financial stability and the market's level of confidence in the issuer's capital.

Who Scholar Rock competes with